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Introduction: Currently, on-line hemodiaﬁltration (OL-HDF) is the most effective technique.
Several randomised studies and meta-analyses have shown a reduced mortality and a direct
association with convective volume has been reported. At present, it has not been estab-
lished if an increased dialysate ﬂow (Qd) shows in improved results in terms of convective
and depurative efﬁciency. We  aim at assessing the effects of Qd variations on convective
volume and its depurative capacity in patients on OL-HDF.
Material and methods: A total of 59 patients (45 men and 14 women) from a OL-HDF pro-
gramme in which a monitor 5008 Cordiax with auto-substitution was used, were enrolled.
Patients were assessed in 5 sessions with post-dilutional OL-HDF, using helixone-based dia-
lyzers, with only Qd being changed (300, 400, 500, 600 and 700 mL/min). Serum levels of
urea (60 Da), creatinine (113 Da), 2-microglobulin (11,800 Da), myoglobin (17,200 Da) and 1-
microglobulin (33,000 Da) were measured at the beginning and at the end of each session,
in  order to estimate the percent reduction of such solutes.
Results: An increased dialysate volume per session was observed, from 117.9 ± 6.4 L with
Qd  300 mL/min to 232.4 ± 12 L with Qd 700 mL/min. No changes were found in replacement
volume or convective volume. Regarding diffusion, Qd increase was associated to a signif-
icantly increased dialysis dose, with an increased Kt from 68 ± 6.9 L with Qd 300 mL/min
to  75.5 ± 7.3 L with Qd 700 mL/min (P < 0.001), and a gradually increased percent reduction
in  urea associated to increased Qd with signiﬁcantly lower levels being found with Qd
300  mL/min. No changes were found in other measured substances.
Conclusion: Qd variations in OL-HDF do not change convective volume. A higher Qd was
associated to a slightly increased urea clearance with no change being observed for medium
and large molecules. Qd optimisation to the minimal level assuring an adequate dialysis
dose  and allowing water and dialysate use to be rationalised should be recommended.©  2015 The Authors. Published by Elsevier España, S.L.U. on behalf of Sociedad Española
de  Nefrología. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Optimización  del  ﬂujo  del  líquido  de  diálisis  en  la  hemodiaﬁltración
on-line
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r  e  s  u  m  e  n
Introducción: La hemodiaﬁltración on-line (HDF-OL) es actualmente la técnica más efectiva.
Varios estudios aleatorizados y metaanálisis han observado una reducción de la mortalidad,
con  una asociación en relación directa con el volumen convectivo. En el momento presente
no  está bien establecido si el aumento del ﬂujo del líquido de diálisis (Qd) puede suponer
mejores resultados en términos de eﬁcacia convectiva y depurativa. El objetivo del estudio
fue valorar, en pacientes en tratamiento con HDF-OL, el efecto de la variación del Qd sobre
el  volumen convectivo y su capacidad depurativa.
Material y métodos: Se incluyeron 59 pacientes, 45 varones y 14 mujeres que se encontraban
en  programa de HDF-OL con monitor 5008 Cordiax con autosustitución. Cada paciente fue
analizado en 5 sesiones con HDF-OL posdilucional, con dializadores de helixona, en las
que  solo se varió el Qd (300, 400, 500, 600 y 700 ml/min). En cada sesión se determinaron
concentración de urea (60 Da), creatinina (113 Da), 2-microglobulina (11.800 Da), mioglobina
(17.200 Da) y 1-microglobulina (33.000 Da) en suero al inicio y al ﬁnal de cada sesión, para
calcular el porcentaje de reducción de estos solutos.
Resultados: Se objetivó un aumento de litros de Qd por sesión, desde 117,9 ± 6,4 L con Qd de
300  ml/min hasta 232,4 ± 12 L con Qd 700 ml/min. No se determinaron cambios en el vol-
umen de sustitución ni en el volumen convectivo. En términos de difusión, el incremento
del  Qd mostró un aumento signiﬁcativo de la dosis de diálisis, con un aumento de Kt de
68  ± 6,9 L con Qd 300 ml/min hasta 75,5 ± 7,3 L con Qd 700 ml/min (p < 0,001), y un aumento
progresivo del porcentaje de reducción de urea con el incremento del Qd, que era signiﬁca-
tivamente inferior con Qd 300 ml/min. No se objetivaron cambios en el resto de moléculas
estudiadas.
Conclusión: La variación del Qd en HDF-OL no modiﬁca el volumen convectivo. Un mayor Qd
mostró un discreto incremento de la depuración de la urea, sin variaciones en las medianas
ni  en las grandes moléculas. Es recomendable optimizar el Qd al mínimo posible que garan-
tice  una adecuada dosis de diálisis y permita racionalizar el consumo de agua y concentrado
de  diálisis.
© 2015 The Authors. Publicado por Elsevier España, S.L.U. en nombre de Sociedad Española
de  Nefrología. Este es un artículo Open Access bajo la licencia CC BY-NC-NDIntroduction
National1 and international2 clinical practice guidelines rec-
ommend to provide at least a minimum dose of haemodialysis
as determined by a Kt/V of 1.3 and a urea reduction ratio of
70%. Diffusive clearance is related to blood ﬂow (Qb), dialysate
ﬂow (Qd), and the mass transfer-area coefﬁcient (KoA). In one
in vitro study, Leypoldt et al.3 showed that an increase in
Qd from 500 mL/min to 800 mL/min conferred a 14% increase
in urea KoA, due to improved distribution of dialysate and
reduced mass transfer resistance across the membrane. These
results were subsequently demonstrated in clinical practice,
with a 5.7%4 increase in KoA and an 8.5% increase in K and
Kt/V when Qd was changed from 500 mL/min to 750 mL/min.5
Through modiﬁcations in the manufacturing of dialyzers, the
pharmaceutical industry has improved dialysate distribution
in capillaries.6–8 It has been observed that an increase in Qd
to beyond 600 mL/min does not correlate with better dialysis
outcomes, as determined by Kt/V9 or clearance of molecules
such as phosphorus and 2-microglobulin.10
Haemodiaﬁltration is a dialysis technique that combines
diffusion and convection, both processes having similar(http://creativecommons.org/licenses/by-nc-nd/4.0/).
clearance capacities. Post-dilution on-line HDF (OL-HDF) has
been demonstrated to improve intradialysis tolerance11,
increase survival12 and more  recently, several meta-
analyses have conﬁrmed reduced overall and cardiovascular
mortality.12–15 Secondary analyses of the studies using death
as a primary endpoint11,14,15 observed an association between
convective volume and survival. Therefore, a minimum con-
vective volume of 23 L per session was recommended until
more  conclusive scientiﬁc evidence became available.16,17
Initially, OL-HDF was performed with a Qd of 800 mL/min,
because some of the dialysate was used as substitution
solution.18,19 Later, newer monitors were able to differenti-
ate dialysate destined for diffusion (usually 500 mL/min) from
that destined for substitution (60–150 mL/min).20 Now, with
the aim of optimising the dialysate to the requirements of
the dialyser, the 5008 monitors have a Qd autoﬂow system
with an adjustable Qd/Qb ratio. The initial default setting
recommended by the monitor for this factor was 1.2.21 This
recommendation has subsequently been changed to a factor
of 1.0 if Qb is equal to or greater than 400 mL/min, or 1.2 if Qb
is less than 400 mL/min.
To assess and optimise the choice of dialysate, the aim of
this study was to evaluate the effects of changes in Qd on the
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onvective volume and clearance capacity in patients on OL-
DF treatment.
atients  and  methods
his was a single-centre study in stable haemodialysis
atients. Fifty-nine patients were included, 45 men  and 14
omen, with a mean age of 67.0 ± 13 years (range 26–89
ears), who were on a haemodialysis programme for a mean
f 39.4 ± 42 months. The aetiology of chronic renal failure
as  chronic glomerulonephritis in 8 cases (13.6%), diabetic
ephropathy in 14 cases (23.7%), polycystic disease in 6 cases
10.2%), vascular nephropathy in 13 cases (22%), urological
auses in 6 cases (10.2%), systemic disease in 1 (1.7%), tubulo-
nterstitial nephritis in 2 (3.4%), and unknown aetiology in
 (15.3%). All patients were dialysed via an arteriovenous
stula, except one patient who had a tunnelled central
ine.
Each patient received 5 different dialysis sessions, always
id-week, in which only Qd was changed, to either 300, 400,
00, 600, or 700 mL/min. Other dialytic parameters were kept
onstant in all sessions studied: dialysis time, 293.4 ± 15 min
240–300 min); Qb, 424 ± 4 mL/min (350–450 mL/min). The dial-
ser was not changed (80% FX60Cordiax, 20% FX80Cordiax),
008 Cordiax monitor, post-dilution OL-HDF with auto-
ubstitution system was used. The order of sessions was
andomised.
The dialysis parameters collected at each session were:
rogrammed time, actual duration of sessions; dialyser; Qb;
nitial and ﬁnal weight; Kt, automatically measured by ionic
ialysance; recirculation rate, measured by the temperature
odule; arterial pressure; venous pressure; transmembrane
ressure; initial and ﬁnal haemoglobin; volume of blood
rocessed; and substitution volume.
Serum concentrations of urea (60 Da), creatinine (113 Da),
2-microglobulin (11,800 Da), myoglobin (17,200 Da) and 1-
icroglobulin (33,000 Da) were measured at the start and
nd of each session to calculate the percentage reduc-
ion of these solutes. The concentrations of urea and
reatinine were measured using molecular absorption spec-
rometry on the ADVIA 2400 analyser (Chemistry System
f Siemens Healthcare Diagnostics, Chicago, IL, USA). 2-
icroglobulin (2-m)  and 1-microglobulin (1-m)  were
easured by immunonephelometry with the BNII analyser
Siemens Healthcare Diagnostics). Myoglobin concentrations
ere measured by “sandwich” enzyme immunoassay with the
imension EXL analyser (Siemens Healthcare Diagnostics). In
ll cases, dedicated reagents were used.
To correct for haemoconcentration during dialysis, the per-
entage reductions pre- and post-treatment in plasma 2-m,
yoglobin and 1-microglobulin were calculated using the
ergström and Wehle formula.22
Statistical analysis was performed on the programme SPSS
ersion 20.0 and results are expressed as mean ± standard
eviation. For analysis of the statistical signiﬁcance of quan-
itative parameters, the Student’s t-test was used for paired
ata, or ANOVA for repeated measures. A P-value < 0.05 was
onsidered statistically signiﬁcant.(5):473–478 475
Results
All dialysis sessions were carried out with no clinical inci-
dents of note. The anticoagulation used was heparin sodium
in 28.8%, low molecular weight heparin (tinzaparin) in 55.9%,
and in the remaining 15.3%, no heparin was used.
The volume of dialysate passed per session increased from
117.9 ± 6.4 L with a Qd of 300 mL/min up to 232.4 ± 12 L with
a Qd of 700 mL/min (Fig. 1). There were no differences in
the other dialysis parameters, Qb, total blood processed by
the monitor, needle gauge, recirculation, actual duration of
sessions, initial weight, ﬁnal weight, weight gain, or dialy-
sis monitor measurements of initial and ﬁnal haematocrit
(Table 1).
The substitution volume was similar in all 5 Qd settings
studied (Table 2), demonstrating that Qd affected neither sub-
stitution volume nor convective volume (Fig. 2). Table 2 shows
that in all situations, there were no differences in arterial
pressure, venous pressure, transmembrane pressure, Qi, ultra-
ﬁltration ﬂow (QUF), or percentage of effective convective
volume over total processed blood.
When Qd was increased, the dialysis dose and clearance
of small molecules also increased. Kt increased signiﬁcantly,
from 68.0 ± 6.9 L when Qd was 300 mL/min, up to 75.5 ± 7.3 L
when Qd was 700 mL/min (Table 3), P < 0.001 in all situations.
There was also a greater percentage reduction of urea with
the increase in Qd, being signiﬁcantly lower when Qd was
300 mL/min than in the other 4 study situations (Table 3).
When we evaluated the percentage reduction of creatinine,
2-m,  myoglobin and 1-microglobulin, no signiﬁcant differ-
ences were observed among the different study situations
(Table 3).
Discussion
This study shows, in post-dilution OL-HDF, the compari-100.0
300 400 500 600
Qd (ml/min)
700
Fig. 1 – Changes in dialysate volume according to Qd;
n = 59; ANOVA for repeated measures.
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Table 1 – Comparison of dialysis parameters for the 5 different Qd settings (n = 59).
Qd (mL/min) 300 400 500 600 700 P
Qb (mL/min) 423.72 ± 4 423.72 ± 4 423.72 ± 4 423.72 ± 4 423.72 ± 4 NS
Processed blood volume (L) 121.65 ± 10 122.04 ± 10 121.71 ± 10 121.49 ± 11 121.41 ± 11 NS
Needle gauge 15/16 (%) 8.6/91.4 8.6/91.4 8.6/91.4 8.6/91.4 8.6/91.4 NS
Recirculation (%) 14.17 ± 5.5 14.24 ± 4.2 14.36 ± 4.5 14.56 ± 4.7 15.1 ± 3.4 NS
Prescribed Td (min) 293.4 ± 15 293.4 ± 15 293.4 ± 15 293.4 ± 15 293.4 ± 15 NS
Delivered Td (min) 288.1 ± 15 288.8 ± 15 288.1 ± 15 287.6 ± 16 287.1 ± 16 NS
Initial weight (kg) 71.46 ± 17 71.30 ± 17 71.39 ± 17 71.14 ± 17 70.71 ± 17 NS
Final weight (kg) 69.39 ± 16 69.31 ± 16 69.35 ± 16 69.00 ± 16 68.53 ± 16 NS
Weight gain (kg) 2.07 ± 0.99 2.00 ± 1.00 2.05 ± 1.02 2.15 ± 0.95 2.10 ± 1.11 NS
Initial haematocrit (%) 30.9 ± 3.6 31.1 ± 4.5 31.3 ± 4.3 30.3 ± 3.9 30.9 ± 3.8 NS
Final haematocrit (%) 36.2 ± 5.4 35.9 ± 5.3 36.4 ± 5.6 35.4 ± 5.5 36.1 ± 5.2 NS
NS, not signiﬁcant; Qb, blood ﬂow; Qd, dialysate ﬂow; Td, dialysis time.
Table 2 – Comparison of substitution volume, total convective volume, infusion ﬂow, ultraﬁltration ﬂow, and processed
blood volume at different dialysate ﬂow rates (n = 59).
Qd 300 400 500 600 700 P
Arterial pressure (mmHg) −225 ± 23 −222 ± 26 −224 ± 28 −225 ± 26 −222 ± 23 NS
Venous pressure (mmHg) 217 ± 33 218 ± 26 216 ± 31 213 ± 25 216 ± 31 NS
TMP (mmHg) 185.2 ± 19 188.9 ± 19 185.1 ± 23 185.5 ± 22 185.3 ± 18 NS
Substitution volume (L/session) 31.39 ± 3.2 31.92 ± 3.2 31.61 ± 3.4 31.79 ± 3.6 31.28 ± 3.1 NS
Convective volume (L/session) 33.47 ± 3.0 33.90 ± 2.9 33.66 ± 3.2 33.94 ± 3.4 33.44 ± 3.1 NS
Qi (mL/min) 109.2 ± 10 110.4 ± 11 109.8 ± 12 110.6 ± 12 109.2 ± 10 NS
QUF (mL/min) 116.2 ± 10 117.5 ± 10 116.9 ± 11 118.0 ± 12 116.7 ± 10 NS
Percentage of convective volume over processed blood (%) 27.6 ± 2.5 28.3 ± 3.9 27.7 ± 2.6 28.0 ± 2.8 27.6 ± 2.3 NS
n ﬂowNS, not signiﬁcant; P, probability; Qi, infusion ﬂow; QUF, ultraﬁltratio
convective volume. In addition, a slight increase was observed
in urea clearance, with no changes in the other molecules
studied: creatinine, 2-m,  myoglobin, and 1-microglobulin.
Therefore, it seems reasonable to optimise Qd to values
that guarantee an adequate dialysis dose, considering that
every 100 mL/min reduction in Qd equates to a 16% reduction
in dialysate consumption: approximately 6 L per hour of
dialysis.On-line HDF is a safe technique that improves intradia-
lytic tolerance11 and increases survival.12–15 The EuDial group
redeﬁned HDF as a blood puriﬁcation therapy combining
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Fig. 2 – Changes in convective volume according to Qd;
n = 59; ANOVA for repeated measures.; TMP, transmembrane pressure.
diffusive and convective solute transport using a high-ﬂux
membrane with a KUF (ultraﬁltration coefﬁcient) greater than
20 mL/h/mmHg/m2 and a sieving coefﬁcient for 2-m greater
than 0.6, with an effective convective volume greater than 20%
of the total blood volume processed,16 and no speciﬁcation
regarding Qd.
The main limiting factors in achieving high convective vol-
umes are Qb, duration of session, and haemoconcentration.
One previous study23 showed that increasing Qb was likely to
be the best method to achieve a greater convective volume:
for every 50 mL/min increase in Qb, the convective volume
increased more  than half a litre per hour. One subsequent
study24 analysed the importance of dialyser surface area. The
authors concluded that with the high ﬂux dialysers currently
available for OL-HDF modes, choice of dialyser surface area
should be considered in the cost effectiveness; when KUF was
greater than 45 mL/h/mmHg, the differences in both convec-
tive volume and clearance capacity were minimal. Increasing
the duration of sessions will always be beneﬁcial in achieving
a greater convective volume and greater clearance capacity.
The present study conﬁrms the null inﬂuence that Qd has on
convective volume.
Regarding clearance efﬁciency, only diffusion is affected by
Qd. Clearance capacity for small molecules depends mainly
on Qb, Qd, and the properties of the membrane (KoA).
Clearance capacity for low molecular weight molecules can
decrease with the increase in spaces not adequately reached
by dialysate, because the yield worsens. Initially, increasing
Qd was recommended to avoid this phenomenon, but in both
in vitro and in vivo studies,3–5 only slight improvements in
clearance were observed with an increase in Qd.
n e f r o l o g i a. 2 0 1 5;3  5(5):473–478 477
Table 3 – Evaluation of the clearance efﬁciency at the difference dialysate ﬂow rates (n = 59).
Qd 300 400 500 600 700
Kt (L) 68.0 ± 6.9 71.3 ± 6.9a 73.2 ± 6.6a,b 75.1 ± 7.7a,b,c 75.5 ± 7.3a,b,d
% reduction urea 82.5 ± 4.9 83.6 ± 5.1e 84.0 ± 4.8f 84.5 ± 5.4a 84.1 ± 4.8a
% reduction Cr 76.5 ± 4.9 77.0 ± 5.1 77.6 ± 5.5 77.4 ± 5.3 77.0 ± 5.2
% reduction 2-m 83.5 ± 4.3 83.8 ± 4.5 83.6 ± 4.3 83.9 ± 4.7 83.2 ± 4.1
% reduction myoglobin 72.1 ± 7.9 71.4 ± 7.3 71.8 ± 8.0 72.1 ± 8.3 70.2 ± 7.3
% reduction 1-microglobulin 20.9 ± 9.1 21.5 ± 7.8 19.6 ± 9.2 22.8 ± 9.3 20.7 ± 8.3
a P < 0.001 compared with 300.
b P < 0.001 compared with 400.
c P = 0.003 compared with 500.
d P < 0.001 compared with 500.
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1e P = 0.018 compared with 300.
f P = 0.004 compared with 300.
In recent years, the pharmaceutical industry, after studying
lassic dialysers with magnetic resonance imaging and com-
uted tomography and observing spaces to which dialysate
as not adequately distributed, introduced changes in the
anufacture of dialysers.6–8 These structural modiﬁcations,
imed at changing the arrangement and packing of capillaries
o make up the membrane, have optimised dialysate distri-
ution across the membrane, thus improving yield. Following
he introduction of these structural modiﬁcations, both in
itro6–8 and in vivo9,10 studies have demonstrated that an
ncrease in Qd beyond 600 mL/min does not lead to a bet-
er clearance capacity in terms of Kt/V,9 KoA, phosphorus,
r 2-microglobulin.10 Therefore, the diffusive efﬁciency con-
erred by Qd has decreased with the modiﬁcations in the
ialyser manufacturing process, and it cannot be claimed that
n increase in Qd leads to improved clearance. Nonetheless,
he prescribing doctor must always individualise the dialy-
is parameters, including Qd, to achieve a minimum dose
f Kt.
One limitation of this study is that it involved only one
ype of dialyser, with a helixone membrane. Therefore, further
tudies with different membranes and dialyser characteristics
re needed to assess whether these results can be extrapolated
r whether Qd should be individualised to each dialyser.
Using previously published data, and after analysing the
esults of this study, it seems reasonable to dialyse with a Qd
f 400 mL/min or with a Qd/Qb autoﬂow of 1.0 when Qb is equal
o or greater than 400 mL/min. This Qd is sufﬁcient to achieve
n adequate clearance capacity, optimising the dialysate used
n each session.
onclusion
ialysate ﬂow in OL-HDF does not affect convective volume. A
igher Qd results in a slight increase in clearance capacity for
rea (diffusion dependent), with no changes for medium and
arge molecules (convection dependent). It is recommended
hat Qd to be optimised to the minimum possible that guar-
ntees an adequate dialysis dose (Kt or Kt/V) and allows
ationalisation of water and dialysis concentrate consump-
ion. Further studies are needed with different dialysers, to
ssess it these results can be extrapolated to all dialysers or if
t is necessary to individualise Qd to each dialyser.
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